What does this research mean for the field?

Levodopa partially restores whole-body gait mechanics and vertical center of mass displacement in Parkinson's disease by reorganizing muscle synergy structures, specifically by increasing gastrocnemius contribution during push-off. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To investigate how levodopa affects vertical center of mass displacement and neuromuscular coordination (muscle synergies) during walking in individuals with Parkinson's disease.

August 26, 2026Experimental Brain ResearchOpen Access

Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait

View Full Paper

Ask AI

Bookmark

To investigate how levodopa affects vertical center of mass displacement and neuromuscular coordination (muscle synergies) during walking in individuals with Parkinson's disease.
Assessed 15 patients with Parkinson's disease (Hoehn & Yahr stages 2–3) during both PD OFF (before levodopa) and PD ON (after levodopa) states, and compared them to 9 healthy older adults.
Recorded kinematics and surface electromyography (EMG) during overground walking to calculate vertical center of mass (vCoM) displacement and extract spatial and temporal muscle synergy patterns.
Levodopa significantly increased maximum vCoM displacement in PD ON compared to PD OFF (p = 0.002), shifting vCoM displacement toward healthy patterns (PD OFF vs healthy: p < 0.001; PD ON vs healthy: not significantly different).
PD OFF showed prolonged activation duration and slower slope-to-peak in push-off synergy (Synergy 2) relative to healthy adults, while levodopa significantly enhanced gastrocnemius muscle contribution within Synergy 2 (PD ON vs PD OFF: p = 0.002).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Controlled crossover study demonstrates levodopa improves vertical center of mass displacement and alters muscle synergies in Parkinson's disease, suggesting restored neuromuscular gait dynamics.

Cite This Study

Aydin et al. (2026) studied this question.

synapsesocial.com/papers/6a8e9b68451774b83f3b42bc https://doi.org/10.1007/s00221-026-07383-x

View Full Paper

Ask AI

Bookmark

Implication

Controlled crossover study demonstrates levodopa improves vertical center of mass displacement and alters muscle synergies in Parkinson's disease, suggesting restored neuromuscular gait dynamics.

Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait

Key Points

Discussion

Implication

Cite This Study

Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait

Key Points

Discussion

Implication

Cite This Study